Cargando…
Meclozine ameliorates bone mineralization and growth plate structure in a mouse model of X‑linked hypophosphatemia
X-linked hypophosphatemic rickets (XLH) is characterized by hypo-mineralization of the bone due to hypophosphatemia. XLH is caused by abnormally high levels of fibroblast growth factor 23, which trigger renal phosphate wasting. Activated fibroblast growth factor receptor 3 (FGFR3) signaling is consi...
Autores principales: | Kamiya, Yasunari, Matsushita, Masaki, Mishima, Kenichi, Ohkawara, Bisei, Michigami, Toshimi, Imagama, Shiro, Ohno, Kinji, Kitoh, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764053/ https://www.ncbi.nlm.nih.gov/pubmed/36569439 http://dx.doi.org/10.3892/etm.2022.11738 |
Ejemplares similares
-
Meclozine Facilitates Proliferation and Differentiation of Chondrocytes by Attenuating Abnormally Activated FGFR3 Signaling in Achondroplasia
por: Matsushita, Masaki, et al.
Publicado: (2013) -
Activated FGFR3 suppresses bone regeneration and bone mineralization in an ovariectomized mouse model
por: Kawashima, Itaru, et al.
Publicado: (2023) -
Clinical dosage of meclozine promotes longitudinal bone growth, bone volume, and trabecular bone quality in transgenic mice with achondroplasia
por: Matsushita, Masaki, et al.
Publicado: (2017) -
Meclozine Attenuates the MARK Pathway in Mammalian Chondrocytes and Ameliorates FGF2-Induced Bone Hyperossification in Larval Zebrafish
por: Takemoto, Genta, et al.
Publicado: (2022) -
Predictive ability of inflammatory markers and laboratory parameters in Legg-Calvé-Perthes disease: A single-center retrospective comparative study
por: Mishima, Kenichi, et al.
Publicado: (2022)